Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor selective and biodegradable cyclotriphosphazene-platinum(II) conjugate anticancer agent, and preparation method thereof

Tumor selective and biodegradable cyclotriphosphazene-platinum(II) conjugate anticancer agent, and preparation method thereof

US Patent 8030506 · Granted Oct 4, 2011

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2024
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2024
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2021
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2021
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2020
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2020
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2020
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2020
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2019
Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and 2019
Dendritic oligopeptide-grafteded cyclotriphosphazene, a process for the preparat2013
Dendritic oligopeptide-grafteded cyclotriphosphazene, a process for the preparat2013